Skip to main content
SpringerLink
Log in

Bone Pain Associated with Cancer Metastasis

  • Chapter
  • First Online:
Bone and Cancer

Part of the book series: Topics in Bone Biology ((TBB,volume 5))

  • 1005 Accesses

Abstract

In 2005, cancer was second only to heart disease as the leading cause of death in the United States. There are 1.4 million new cases of cancer diagnosed each year resulting in over one-half of a million deaths. Due to improvements in detection and treatment, longer patient survival after diagnosis is now possible. Unfortunately, the quality of life in patients dealing with advanced cancer is significantly reduced. A major contributor to the overall decreased quality of life in such patients is bone cancer pain [12, 45].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ACR: American Cancer Society: Annual Cancer Statistics for the US in 2003. 2004.

    Google Scholar 

  2. Ahmed SI, Thompson J, Coulson JM, Woll PJ. (2000) Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. American Journal of Respiratory Cell & Molecular Biology. 22:422–31.

    CAS  Google Scholar 

  3. Alanen K, Deng DX, Chakrabarti S. (2000) Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology. 36:161–7.

    Article  PubMed  CAS  Google Scholar 

  4. Andreev N, Dimitrieva N, Koltzenburg M, McMahon SB. (1995) Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain. 63:109–15.

    Article  PubMed  CAS  Google Scholar 

  5. Asham E, Shankar A, Loizidou M, Fredericks S, Miller K, Boulos PB, Burnstock G, Taylor I. (2001) Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. British Journal of Cancer. 85:1759–63.

    Article  PubMed  CAS  Google Scholar 

  6. Basbaum AI, Jessel, T.M.: The perception of pain. In: Principles of Neural Science, edited by Kandell ER, Schwartz JH, Jessell TM. New York, McGraw-Hill, pp. 472–490.

    Google Scholar 

  7. Berenson JR. (2001) Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials. Seminars in Oncology. 28:25–34.

    Article  PubMed  CAS  Google Scholar 

  8. Cain DM, Wacnik PW, Turner M, Wendelschafer-Crabb G, Kennedy WR, Wilcox GL, Simone DA. (2001) Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. Journal of Neuroscience. 21:9367–76.

    PubMed  CAS  Google Scholar 

  9. Clohisy DR. (2003) Metastatic bone disease: future directions. Clinical Orthopaedics & Related Research. 415:S95–9.

    Google Scholar 

  10. Clohisy DR, Mantyh PW. (2003) Bone cancer pain. Cancer. 97:866–73.

    Article  PubMed  Google Scholar 

  11. Clohisy DR, Perkins SL, Ramnaraine ML. (2000) Review of cellular mechanisms of tumor osteolysis. Clinical Orthopaedics & Related Research. 373:104–14.

    Google Scholar 

  12. Coleman RE. (1997) Skeletal complications of malignancy. Cancer. 80:1588–94.

    Article  PubMed  CAS  Google Scholar 

  13. Couture R, Harrisson M, Vianna RM, Cloutier F. (2001) Kinin receptors in pain and inflammation. European Journal of Pharmacology. 429:161–76.

    Article  PubMed  CAS  Google Scholar 

  14. Croucher PI, Shipman CM, Lippitt J, Perry M, Asosingh K, Hijzen A, Brabbs AC, van Beek EJ, Holen I, Skerry TM, Dunstan CR, Russell GR, Van Camp B, Vanderkerken K. (2001) Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.[see comment]. Blood. 98:3534–40.

    Article  PubMed  CAS  Google Scholar 

  15. Daughaday WH, Deuel TF. (1991) Tumor secretion of growth factors. Endocrinology & Metabolism Clinics of North America. 20:539–63.

    CAS  Google Scholar 

  16. Davar G, Hans G, Fareed MU, Sinnott C, Strichartz G. (1998) Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport. 9:2279–83.

    Article  PubMed  CAS  Google Scholar 

  17. DeLeo JA, Yezierski RP. (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 90:1–6.

    Article  PubMed  CAS  Google Scholar 

  18. Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H. (2001) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. Journal of Biological Chemistry. 276:17864–70.

    Article  PubMed  CAS  Google Scholar 

  19. Djouhri L, Bleazard L, Lawson SN. (1998) Association of somatic action potential shape with sensory receptive properties in guinea-pig dorsal root ganglion neurones. Journal of Physiology. 513:857–72.

    Article  PubMed  CAS  Google Scholar 

  20. DuBois RN, Radhika A, Reddy BS, Entingh AJ. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110: 1259–62.

    Article  PubMed  CAS  Google Scholar 

  21. Foley KM. (1999) Advances in cancer pain. Arch Neurol. 56:413–7.

    Article  PubMed  CAS  Google Scholar 

  22. Fox A, Wotherspoon G, McNair K, Hudson L, Patel S, Gentry C, Winter J. (2003) Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain. 104:683–91.

    Article  PubMed  CAS  Google Scholar 

  23. Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C. (1998) The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain. 78:157–69.

    Article  PubMed  CAS  Google Scholar 

  24. Galasko CS. (1995) Diagnosis of skeletal metastases and assessment of response to treatment. Clinical Orthopaedics & Related Research.64–75.

    Google Scholar 

  25. Goblirsch MJ, Zwolak P, Clohisy DR. (2005) Advances in understanding bone cancer pain. Journal of Cellular Biochemistry . 96:682–8.

    Article  PubMed  CAS  Google Scholar 

  26. Halvorson KG et al. (2006) Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin J. of Pain. 22(7): 587–600.

    Article  Google Scholar 

  27. Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE, Ghilardi JR, Rosol TJ, Boustany L, Shelton DL, Mantyh PW. (2005) A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Research. 65:9426–35.

    Article  PubMed  CAS  Google Scholar 

  28. Harris RE, Alshafie GA, Abou-Issa H, Seibert K. (2000) Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Research. 60: 2101–3.

    PubMed  CAS  Google Scholar 

  29. Harrington K.D. (1997) Orthopedic surgical management of skeletal complications of malignancy. Cancer. 80(8 Suppl.):1614–27.

    Article  PubMed  CAS  Google Scholar 

  30. Hill EL, Elde R. (1988) Calcitonin gene-related peptide-immunoreactive nerve fibers in mandibular periosteum of rat: evidence for primary afferent origin. Neuroscience Letters. 85:172–8.

    Article  PubMed  CAS  Google Scholar 

  31. Hohmann EL, Elde RP, Rysavy JA, Einzig S, Gebhard RL. (1986) Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science. 232:868–71.

    Article  PubMed  CAS  Google Scholar 

  32. Honore P, Schwei J, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW. (2000) Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Progress in Brain Research. 129:389–97.

    Article  PubMed  CAS  Google Scholar 

  33. Hunt SP, Mantyh PW. (2001) The molecular dynamics of pain control. Nature Reviews. Neuroscience. 2:83–91.

    Article  PubMed  CAS  Google Scholar 

  34. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. (2006) Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. 56:106–30.

    Article  Google Scholar 

  35. Julius D, Basbaum AI. (2001) Molecular mechanisms of nociception. Nature. 413:203–10.

    Article  PubMed  CAS  Google Scholar 

  36. Koltzenburg M. (1999) The changing sensitivity in the life of the nociceptor. Pain. Suppl 6:S93–102.

    Google Scholar 

  37. Kundu N, Yang Q, Dorsey R, Fulton AM. (2001) Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer. International Journal of Cancer. 93:681–6.

    Article  CAS  Google Scholar 

  38. Kurbel S, Kurbel B, Kovacic D, Sulava D, Krajina Z, Dmitrovic B, Sokcevic M. (1999) Endothelin-secreting tumors and the idea of the pseudoectopic hormone secretion in tumors. Medical Hypotheses. 52:329–33.

    Article  PubMed  CAS  Google Scholar 

  39. Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S. (2001) Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Cancer Research. 61:6131–6.

    PubMed  CAS  Google Scholar 

  40. Lesage P, Portenoy RK. (1999) Trends in Cancer Pain Management. Cancer Control. 6:136–145.

    PubMed  Google Scholar 

  41. Luger NM, Mach DB, Sevcik MA, Mantyh PW. (2005) Bone cancer pain: from model to mechanism to therapy. Journal of Pain and Symptom Management. 29: S32–46.

    Article  PubMed  CAS  Google Scholar 

  42. Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O’Leary P, Mantyh PW. (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 113:155–66.

    Article  PubMed  CAS  Google Scholar 

  43. Major PP, Lipton A, Berenson J, Hortobagyi G. (2000) Oral bisphosphonates: A review of clinical use in patients with bone metastases. Cancer. 88:6–14.

    Article  PubMed  CAS  Google Scholar 

  44. Mantyh PW. (2002) A mechanism based understanding of cancer pain. Pain. 96:1–2.

    Article  PubMed  Google Scholar 

  45. Mantyh PW. (2006) Cancer pain and its impact on diagnosis, survival and quality of life. Nature Reviews Neuroscience. 7:797–809.

    Article  PubMed  CAS  Google Scholar 

  46. Mantyh PW, Hunt SP. (2004) Mechanisms that generate and maintain bone cancer pain. Novartis Foundation Symposium. 260:221–38; discussion 238–40, 277–9.

    Article  PubMed  Google Scholar 

  47. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Research. 60:1306–11.

    PubMed  CAS  Google Scholar 

  48. Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger M, Vaxelaire J, O'Reilly T, Wotherspoon G, Winter J, Green J, Urban L. (2002) A rat model of bone cancer pain. Pain. 96:129–40.

    Article  PubMed  CAS  Google Scholar 

  49. Mercadante S. (1997) Malignant bone pain: pathophysiology and treatment. Pain. 69:1–18.

    Article  PubMed  CAS  Google Scholar 

  50. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. (2001) Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 93:247–57.

    Article  PubMed  CAS  Google Scholar 

  51. Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA. (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Research. 59: 4356–62.

    PubMed  CAS  Google Scholar 

  52. Morony S, Capparelli C, Sarosi I, Lacey DL, Dunstan CR, Kostenuik PJ. (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Research. 61:4432–6.

    PubMed  CAS  Google Scholar 

  53. Morton CL, Houghton PJ. (2007) Establishment of human tumor xenografts in immunodeficient mice. Nature Protocols. 2:247–50.

    Article  PubMed  CAS  Google Scholar 

  54. Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, Yarnold PR, Schaeffer AJ. (2000) IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. Journal of Urology. 164:214–8.

    Article  PubMed  CAS  Google Scholar 

  55. Nelson JB, Carducci MA. (2000) The role of endothelin-1 and endothelin receptor antagonists in prostate cancer. BJU International. 85 Suppl 2:45–8.

    Article  PubMed  CAS  Google Scholar 

  56. Nolte J. (2002) The Human Brain: An Introduction to its Functional Anatomy., St. Louis, MO, Mosby.

    Google Scholar 

  57. Ohno R, Yoshinaga K, Fujita T, Hasegawa K, Iseki H, Tsunozaki H, Ichikawa W, Nihei Z, Sugihara K. (2001) Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer. 91:1876–81.

    Article  PubMed  CAS  Google Scholar 

  58. Oikonomou E, Kothonidis K, Zografos G, Nasioulas G, Andera L, Pintzas A. (2007) Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo. British Journal of Cancer. 97:73–84.

    Article  PubMed  CAS  Google Scholar 

  59. Opree A, Kress M. (2000) Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. Journal of Neuroscience. 20:6289–93.

    PubMed  CAS  Google Scholar 

  60. Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, Mach DB, Schwei MJ, Sevcik MA, Mantyh PW. (2005) Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Experimental Neurology. 193:85–100.

    Article  PubMed  Google Scholar 

  61. Poon RT, Fan ST, Wong J. (2001) Clinical implications of circulating angiogenic factors in cancer patients. Journal of Clinical Oncology. 19:1207–25.

    PubMed  CAS  Google Scholar 

  62. Portenoy RK. (1999) Managing cancer pain poorly responsive to systemic opioid therapy. Oncology (Williston Park). 13:25–9.

    CAS  Google Scholar 

  63. Portenoy RK, Frager G. (1999) Pain management: pharmacological approaches. Cancer Treatmemt and Research 100:1–29.

    Article  CAS  Google Scholar 

  64. Portenoy RK, Lesage P. (1999) Management of cancer pain. Lancet. 353:1695–700.

    Article  PubMed  CAS  Google Scholar 

  65. Portenoy RK, Payne D, Jacobsen P. (1999) Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 81:129–34.

    Article  PubMed  CAS  Google Scholar 

  66. Radinsky R. (1991) Growth factors and their receptors in metastasis. Seminars in Cancer Biology. 2: 169–77.

    PubMed  CAS  Google Scholar 

  67. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. (2000) Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Research. 60:293–7.

    PubMed  CAS  Google Scholar 

  68. Roman C, Saha D, Beauchamp R. (2001) TGF-beta and colorectal carcinogenesis. Microscopy Research & Technique. 52:450–7.

    Article  CAS  Google Scholar 

  69. Sabino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW. (2002) Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res. 62:7343–9.

    PubMed  CAS  Google Scholar 

  70. Sabino MA, Luger NM, Mach DB, Rogers SD, Schwei MJ, Mantyh PW. (2003) Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. International Journal of Cancer. 104:550–8.

    Article  CAS  Google Scholar 

  71. Sabino MA, Mantyh PW. (2005) Pathophysiology of bone cancer pain. The Journal of Supportive Oncology. 3:15–24.

    PubMed  CAS  Google Scholar 

  72. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW. (1999) Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. Journal of Neuroscience. 19:10886–97.

    PubMed  CAS  Google Scholar 

  73. Sevcik MA, Ghilardi JR, Halvorson KG, Lindsay TH, Kubota K, Mantyh PW. (2005) Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model. Journal of Pain. 6:771–5.

    Article  PubMed  CAS  Google Scholar 

  74. Sevcik MA, Luger NM, Mach DB, Sabino MA, Peters CM, Ghilardi JR, Schwei MJ, Rohrich H, De Felipe C, Kuskowski MA, Mantyh PW. (2004) Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Pain. 111:169–80.

    Article  PubMed  CAS  Google Scholar 

  75. Shappell SB, Manning S, Boeglin WE, Guan YF, Roberts RL, Davis L, Olson SJ, Jack GS, Coffey CS, Wheeler TM, Breyer MD, Brash AR. (2001) Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Neoplasia (New York). 3:287–303.

    Article  CAS  Google Scholar 

  76. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. Journal of Clinical Investigation. 99:2254–9.

    Article  PubMed  CAS  Google Scholar 

  77. Shu XQ, Mendell LM. (1999) Neurotrophins and hyperalgesia. Proceedings of the National Academy of Sciences of the United States of America. 96:7693–6.

    Article  PubMed  CAS  Google Scholar 

  78. Silver BJ. (1992) Platelet-derived growth factor in human malignancy. Biofactors. 3:217–27.

    PubMed  CAS  Google Scholar 

  79. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.[see comment]. Cell. 89:309–19.

    Article  PubMed  CAS  Google Scholar 

  80. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, Taketo MM. (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nature Medicine. 7:1048–51.

    Article  PubMed  CAS  Google Scholar 

  81. Stoscheck CM, King LE, Jr. (1986) Role of epidermal growth factor in carcinogenesis. Cancer Research. 46:1030–7.

    PubMed  CAS  Google Scholar 

  82. Wacnik PW, Kehl LJ, Trempe TM, Ramnaraine ML, Beitz AJ, Wilcox GL. (2003) Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain. 101:175–86.

    Article  PubMed  Google Scholar 

  83. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. (1995) Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Research. 692:244–50.

    Article  PubMed  CAS  Google Scholar 

  84. Watkins LR, Maier SF. (1999) Implications of immune-to-brain communication for sickness and pain. Proceedings of the National Academy of Sciences of the United States of America. 96:7710–3.

    Article  PubMed  CAS  Google Scholar 

  85. Watkins LR, Maier SF, Goehler LE. (1995) Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:289–302.

    Article  PubMed  CAS  Google Scholar 

  86. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. (2000) Host cyclooxygenase-2 modulates carcinoma growth.[see comment]. Journal of Clinical Investigation. 105:1589–94.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN, USA

    Patrick W. O’Donnell MD, PhD, Nancy M. Luger & Denis R. Clohisy (MD)

Authors
  1. Patrick W. O’Donnell MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy M. Luger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Denis R. Clohisy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

O’Donnell, P.W., Luger, N.M., Clohisy, D.R. (2010). Bone Pain Associated with Cancer Metastasis. In: Bone and Cancer. Topics in Bone Biology, vol 5. Springer, London. https://doi.org/10.1007/978-1-84882-019-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-019-7_11

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-018-0

  • Online ISBN: 978-1-84882-019-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation